TipRanks
Addex Therapeutics (DE:APE1)
FRANKFURT:APE1
Germany Market
APE1
Addex Therapeutics
RESEARCH TOOLSreports

Addex Therapeutics (APE1) Cash flow

0 Followers

Addex Therapeutics Cash Flow

DE:APE1's free cash flow for Q2 2026 was CHF-468.70K. For the 2026 fiscal year, DE:APE1's free cash flow was decreased by CHF3.30M and operating cash flow was CHF-468.69K. See a summary of the company’s cash flow.
Cash Flow
Mar 26Mar 25Mar 24Dec 22Dec 21
Operating Cash Flow
CHF -2.08MCHF -5.37MCHF -7.99MCHF -16.44MCHF -14.71M
Investing Cash Flow
CHF -650.08KCHF 4.65MCHF -6.84KCHF 2.97KCHF -30.31K
Financing Cash Flow
CHF 1.13MCHF 104.92KCHF 5.26MCHF 3.10MCHF 16.40M
End Cash Position
CHF 1.64MCHF 3.34MCHF 3.87MCHF 6.96MCHF 20.48M
Free Cash Flow
CHF -2.08MCHF -5.37MCHF -8.00MCHF -16.44MCHF -14.74M
Currency in CHF

Addex Therapeutics Cash Flow